A Review of Updates to NCCN Evidence-based Guidelines in Advanced Ovarian Cancer

Oct 10, 2022 | Ovarian

2) Earn 0.5hr 🆓CE/#CME credit w/ this 🧵! @onc_ce is your ONLY source for serialized #accredited CE/#CME #tweetorials in #oncology. This program is supported by an educational grant from GSK plc and is intended for healthcare professionals.— @onc_ce (@onc_ce)...

PARP Inhibitors in Ovarian Cancer: Shared Decision-making, Mitigating AEs, & Managing Disparities in Access

Oct 2, 2022 | Ovarian

2) @onc_ce is your ONLY source for serialized #accredited CE/#CME #tweetorials in #oncology. This program is supported by an educational grant from GSK plc and is intended for healthcare professionals. Accreditation statement and faculty disclosures at...

A Scientific Analysis and Clinical Trial Review of PARP Inhibitors for the Maintenance Treatment of Patients with Advanced Ovarian Cancer

Sep 18, 2022 | Ovarian

2) @onc_ce is your ONLY source for serialized #accredited CE/#CME #tweetorials in #oncology. This program is supported by an educational grant from GSK plc and is intended for healthcare professionals. Accreditation statement and faculty disclosures at...

Accredited by:

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Learn More at AcademicCME.com

  • Menu:
  • Home
  • Faculty
  • Disclosures